世界の経口高分子製剤市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Oral Macromolecule Formulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:86
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、経口高分子製剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。経口高分子製剤の種類別市場規模(カプセル、錠剤、液体)、用途別市場規模(病院薬局、小売薬局、オンライン薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Wellchem、Allergan、Synergy Pharmaceuticals、Novo Nordisk A/S、Oramed、Biocon India、Diabetology、Catalent
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:カプセル、錠剤、液体
・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン薬局、その他
・経口高分子製剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経口高分子製剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経口高分子製剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経口高分子製剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経口高分子製剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Oral Macromolecule Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Macromolecule Formulation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Oral Macromolecule Formulation market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Oral Macromolecule Formulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Capsule
Tablet
Liquid

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Market segment by players, this report covers
Wellchem
Allergan
Synergy Pharmaceuticals
Novo Nordisk A/S
Oramed
Biocon India
Diabetology
Catalent

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oral Macromolecule Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oral Macromolecule Formulation, with revenue, gross margin and global market share of Oral Macromolecule Formulation from 2019 to 2021.
Chapter 3, the Oral Macromolecule Formulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oral Macromolecule Formulation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oral Macromolecule Formulation research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Oral Macromolecule Formulation
1.2 Classification of Oral Macromolecule Formulation by Type
1.2.1 Overview: Global Oral Macromolecule Formulation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oral Macromolecule Formulation Revenue Market Share by Type in 2020
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Liquid
1.3 Global Oral Macromolecule Formulation Market by Application
1.3.1 Overview: Global Oral Macromolecule Formulation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Oral Macromolecule Formulation Market Size & Forecast
1.5 Global Oral Macromolecule Formulation Market Size and Forecast by Region
1.5.1 Global Oral Macromolecule Formulation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oral Macromolecule Formulation Market Size by Region, (2016-2021)
1.5.3 North America Oral Macromolecule Formulation Market Size and Prospect (2016-2026)
1.5.4 Europe Oral Macromolecule Formulation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oral Macromolecule Formulation Market Size and Prospect (2016-2026)
1.5.6 South America Oral Macromolecule Formulation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oral Macromolecule Formulation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Macromolecule Formulation Market Drivers
1.6.2 Oral Macromolecule Formulation Market Restraints
1.6.3 Oral Macromolecule Formulation Trends Analysis
2 Company Profiles
2.1 Wellchem
2.1.1 Wellchem Details
2.1.2 Wellchem Major Business
2.1.3 Wellchem Oral Macromolecule Formulation Product and Solutions
2.1.4 Wellchem Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Wellchem Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Oral Macromolecule Formulation Product and Solutions
2.2.4 Allergan Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Synergy Pharmaceuticals
2.3.1 Synergy Pharmaceuticals Details
2.3.2 Synergy Pharmaceuticals Major Business
2.3.3 Synergy Pharmaceuticals Oral Macromolecule Formulation Product and Solutions
2.3.4 Synergy Pharmaceuticals Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Synergy Pharmaceuticals Recent Developments and Future Plans
2.4 Novo Nordisk A/S
2.4.1 Novo Nordisk A/S Details
2.4.2 Novo Nordisk A/S Major Business
2.4.3 Novo Nordisk A/S Oral Macromolecule Formulation Product and Solutions
2.4.4 Novo Nordisk A/S Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novo Nordisk A/S Recent Developments and Future Plans
2.5 Oramed
2.5.1 Oramed Details
2.5.2 Oramed Major Business
2.5.3 Oramed Oral Macromolecule Formulation Product and Solutions
2.5.4 Oramed Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Oramed Recent Developments and Future Plans
2.6 Biocon India
2.6.1 Biocon India Details
2.6.2 Biocon India Major Business
2.6.3 Biocon India Oral Macromolecule Formulation Product and Solutions
2.6.4 Biocon India Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biocon India Recent Developments and Future Plans
2.7 Diabetology
2.7.1 Diabetology Details
2.7.2 Diabetology Major Business
2.7.3 Diabetology Oral Macromolecule Formulation Product and Solutions
2.7.4 Diabetology Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Diabetology Recent Developments and Future Plans
2.8 Catalent
2.8.1 Catalent Details
2.8.2 Catalent Major Business
2.8.3 Catalent Oral Macromolecule Formulation Product and Solutions
2.8.4 Catalent Oral Macromolecule Formulation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Catalent Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Macromolecule Formulation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Oral Macromolecule Formulation Players Market Share
3.2.2 Top 10 Oral Macromolecule Formulation Players Market Share
3.2.3 Market Competition Trend
3.3 Oral Macromolecule Formulation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oral Macromolecule Formulation Revenue and Market Share by Type (2016-2021)
4.2 Global Oral Macromolecule Formulation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oral Macromolecule Formulation Revenue Market Share by Application (2016-2021)
5.2 Oral Macromolecule Formulation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oral Macromolecule Formulation Revenue by Type (2016-2026)
6.2 North America Oral Macromolecule Formulation Revenue by Application (2016-2026)
6.3 North America Oral Macromolecule Formulation Market Size by Country
6.3.1 North America Oral Macromolecule Formulation Revenue by Country (2016-2026)
6.3.2 United States Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
6.3.3 Canada Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
6.3.4 Mexico Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oral Macromolecule Formulation Revenue by Type (2016-2026)
7.2 Europe Oral Macromolecule Formulation Revenue by Application (2016-2026)
7.3 Europe Oral Macromolecule Formulation Market Size by Country
7.3.1 Europe Oral Macromolecule Formulation Revenue by Country (2016-2026)
7.3.2 Germany Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
7.3.3 France Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
7.3.5 Russia Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
7.3.6 Italy Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oral Macromolecule Formulation Revenue by Type (2016-2026)
8.2 Asia-Pacific Oral Macromolecule Formulation Revenue by Application (2016-2026)
8.3 Asia-Pacific Oral Macromolecule Formulation Market Size by Region
8.3.1 Asia-Pacific Oral Macromolecule Formulation Revenue by Region (2016-2026)
8.3.2 China Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8.3.3 Japan Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8.3.4 South Korea Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8.3.5 India Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
8.3.7 Australia Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oral Macromolecule Formulation Revenue by Type (2016-2026)
9.2 South America Oral Macromolecule Formulation Revenue by Application (2016-2026)
9.3 South America Oral Macromolecule Formulation Market Size by Country
9.3.1 South America Oral Macromolecule Formulation Revenue by Country (2016-2026)
9.3.2 Brazil Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
9.3.3 Argentina Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oral Macromolecule Formulation Revenue by Type (2016-2026)
10.2 Middle East & Africa Oral Macromolecule Formulation Revenue by Application (2016-2026)
10.3 Middle East & Africa Oral Macromolecule Formulation Market Size by Country
10.3.1 Middle East & Africa Oral Macromolecule Formulation Revenue by Country (2016-2026)
10.3.2 Turkey Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
10.3.4 UAE Oral Macromolecule Formulation Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Wellchem、Allergan、Synergy Pharmaceuticals、Novo Nordisk A/S、Oramed、Biocon India、Diabetology、Catalent

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経口高分子製剤市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Oral Macromolecule Formulation Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。